publication . Report . Preprint . 2003

Globalisation and its impact on competitiveness : the case of the British and German pharmaceutical industry

Christel Lane; Jocelyn Probert;
Open Access English
  • Published: 01 Jun 2003
  • Publisher: ESRC Centre for Business Research
  • Country: Germany
Abstract
This paper assesses the degree of financial and economic globalisation of British and German pharmaceutical companies during 1990 and 2001 and explores the changing balance between globalisation and national embeddedness. It tries to explain both the much lower degree of globalisation of German as compared to British companies in 1990, as well as their catching up at the beginning of the 21st century. The paper suggests that the lesser degree of globalisation of German firms during most of the 1990s partly explains their slide in competitiveness during this period. The conclusion examines prospects for the future of firms in both economies. The paper draws on de...
Subjects
free text keywords: globalisation, pharmaceutical industry, performance, British-German comparison, ddc:6, ddc:61, ddc:615, jel:L22, jel:L65, jel:P12
Related Organizations
29 references, page 1 of 2

ABPI. 2002. 'Facts and Statistics from the Pharmaceutical Industry'. The Association of the British Pharmaceutical Industry, London, www.abpi.org.uk

ABPI. 2003. 'UK sees healthy growth in investment, but European levels decline', 29 January press release, www.abpi.org.uk

Allansdottir, A., Bonaccorsi, A., Gambardella, A., Mariani, M., Orsenigo, L., Pammolli, F. and Riccaboni, M. 2002. 'Innovation and Competitiveness in European Biotechnology', Enterprise Papers No.7. Brussels: Enterprise Directorate-General European Commission

Becker, S 2001, Einfluss und Grenzen des Shareholder Value. Strategie- und Strukturwandel deutscher Grossunternehmen der chemischen und pharmazeutischen Industrie. Frankfurt am Main: Peter Lang.

Casper, S., Lehrer, M. and Soskice, D. 1999. 'Can high-technology industries prosper in Germany? Institutional frameworks and the evolution of the German software and biotechnology industries' Industry and Innovation, 6(1): 5-24.

Corley T.A.B. 1999. 'The British Pharmaceutical Industry since 1851'. University of Reading Department of Economics, Working paper No.404: Reading

EFPIA. 2001. 'The Pharmaceutical Industry in Figures'. www.efpia.org

EFPIA. 2002. '2001-2002: The Year in Review'. www.efpia.org

Froud, J., Haslam, C. Johal, S. Williams, K. and Willis, R. 1998. 'British pharmaceuticals: a cautionary tale', Economy and Society, 27(4): 554-84. [OpenAIRE]

Gambardella, A., Orsenigo, L. and Pammolli, F. 2000. Global Competitiveness in Pharmaceuticals, A European Perspective, Report for the Directorate General Enterprise of the European Commission [OpenAIRE]

Hoepner, M. 2001. 'Corporate Governance in Transition: ten empirical findings on shareholder value and industrial relations'. Discussion Paper 01/5. Cologne: Max-Planck-Institut f. Gesellschaftsforschung.

Jacobzone, S. 2000. Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals, Labour Market and Social Policy Occasional Papers No.40, Paris.

Keck, O. 1993. 'The National System for Technical Innovation in Germany', in R. Nelson (ed.), National Innovation Systems, A Comparative Analysis. Oxford: Oxford University Press, pp.115-191

Kettler, H.E. and Casper, S. 2000. The Road to Sustainability in the UK and German Biotechnology Industries. London, Office of Health Economics.

Lane, C. 1992, 'European Business Systems: Britain and Germany Compared', R. Whitley (ed.), European Business Systems. London: Sage.

29 references, page 1 of 2
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Report . Preprint . 2003

Globalisation and its impact on competitiveness : the case of the British and German pharmaceutical industry

Christel Lane; Jocelyn Probert;